| Literature DB >> 30197612 |
Abstract
The effectiveness of EMDR therapy in treating veterans diagnosed with PTSD was evaluated in this study using two treatment formats: intensive daily EMDR treatment provided twice a day during a 10-day period and a second format of one session each week. The study used archived outcome data previously collected and stored at Soldier Center. Both formats provided 18-20 treatment sessions of EMDR therapy to veterans diagnosed with PTSD that included dissociative exhibitions and moral injury issues. Questions addressed included: (1) does EMDR therapy administered twice daily ameliorate veterans' PTSD symptoms; (2) does EMDR therapy administered twice daily provide equivalent outcome results as EMDR therapy administered weekly for 18-20 sessions; and (3) does the treatment outcome persist. The effectiveness of the weekly treatment group was also evaluated. Both groups' results were assessed at pre-treatment, post-treatment and 1-year follow-up. The results indicated that both weekly treatment and intensive daily treatment groups produced statistically significant treatment effects (p < 0.001) that were maintained at 1-year follow-up. The10-day EMDR intensive daily treatment (EMDR therapy twice a day for 10 days) produced a similar outcome as to that of the weekly treatment with a 1-year follow-up. Results support the effectiveness of EMDR therapy when offered in both weekly treatment format as well as the intensive 10-day format on an outpatient basis. While recognizing the limitations of this study the results are significant to warrant additional research.Entities:
Keywords: EMDR; PTSD; complex-PTSD; daily-treatment; moral injury; phantom limb pain
Year: 2018 PMID: 30197612 PMCID: PMC6117416 DOI: 10.3389/fpsyg.2018.01458
Source DB: PubMed Journal: Front Psychol ISSN: 1664-1078
Descriptive statistics.
| Mean | N | Std. Deviation | Minimum | Maximum | |
|---|---|---|---|---|---|
| Intensive daily (Pre) | 53.20 | 15 | 11.321 | 29.00 | 66.00 |
| Intensive daily (Post) | 17.40 | 15 | 13.092 | 0.00 | 39.00 |
| Intensive daily (FU) | 15.60 | 15 | 6.967 | 4.00 | 30.00 |
| Weekly (Pre) | 51.80 | 15 | 8.326 | 35.00 | 63.00 |
| Weekly (Post) | 16.07 | 15 | 6.923 | 8.00 | 33.00 |
| Weekly (FU) | 17.73 | 15 | 5.574 | 5.00 | 25.00 |
Independent samples t-test results for baseline measures of the two treatment groups.
| Levene’s test | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sig. | Sig. (2-tailed) | Mean difference | Std. error difference | 95% CI of the difference | |||||
| Lower | Upper | ||||||||
| Equal variances assumed | 2.556 | 0.121 | 0.386 | 28 | 0.703 | 1.400 | 3.628 | -6.032 | 8.832 |
| Equal variances not assumed | 0.386 | 25.716 | 0.703 | 1.400 | 3.628 | -6.062 | 8.862 | ||
Tests of within-subjects effects for the successive day treatment group.
| Source | Type III sum of squares | Mean square | Sig. | Partial Eta squared | |||
|---|---|---|---|---|---|---|---|
| IES successive day | Sphericity assumed | 13493.200 | 2 | 6746.600 | 105.212 | 0.000 | 0.883 |
| Greenhouse-geisser | 13493.200 | 1.604 | 8409.878 | 105.212 | 0.000 | 0.883 | |
| Huynh-feldt | 13493.200 | 1.780 | 7579.552 | 105.212 | 0.000 | 0.883 | |
| Lower-bound | 13493.200 | 1.000 | 13493.200 | 105.212 | 0.000 | 0.883 | |
| Error | Sphericity assumed | 1795.467 | 28 | 64.124 | |||
| Greenhouse-geisser | 1795.467 | 22.462 | 79.933 | ||||
| Huynh-feldt | 1795.467 | 24.923 | 72.041 | ||||
| Lower-bound | 1795.467 | 14.000 | 128.248 | ||||
Pairwise comparisons for the successive day treatment group.
| (I) IES | (J) IES | Mean difference (I-J) | Std. Error | Sig. | 95% CI for difference | |
|---|---|---|---|---|---|---|
| Lower bound | Upper bound | |||||
| Pre | Post | 35.800∗ | 3.444 | 0.000 | 28.414 | 43.186 |
| FU | 37.600∗ | 3.033 | 0.000 | 31.095 | 44.105 | |
| Post | Pre | -35.800∗ | 3.444 | 0.000 | -43.186 | -28.414 |
| FU | 1.800 | 2.143 | 0.415 | -2.796 | 6.396 | |
| FU | Pre | -37.600∗ | 3.033 | 0.000 | -44.105 | -31.095 |
| Post | -1.800 | 2.143 | 0.415 | -6.396 | 2.796 | |
Tests of Within-Subjects Effects for the Weekly treatment group.
| Source | Type III sum of squares | Mean square | Sig. | Partial eta squared | |||
|---|---|---|---|---|---|---|---|
| IES weekly | Sphericity assumed | 12200.933 | 2 | 6100.467 | 133.964 | 0.000 | 0.905 |
| Greenhouse-geisser | 12200.933 | 1.701 | 7174.429 | 133.964 | 0.000 | 0.905 | |
| Huynh-feldt | 12200.933 | 1.911 | 6383.200 | 133.964 | 0.000 | 0.905 | |
| Lower-bound | 12200.933 | 1.000 | 12200.933 | 133.964 | 0.000 | 0.905 | |
| Error | Sphericity assumed | 1275.067 | 28 | 45.538 | |||
| Greenhouse-geisser | 1275.067 | 23.809 | 53.555 | ||||
| Huynh-feldt | 1275.067 | 26.760 | 47.649 | ||||
| Lower-bound | 1275.067 | 14.000 | 91.076 | ||||
Pairwise comparisons for the weekly treatment group.
| (I) IES | (J) IES | Mean difference (I-J) | Std. Error | Sig. | 95% CI for difference | |
|---|---|---|---|---|---|---|
| Lower bound | Upper bound | |||||
| Pre | Post | 35.733∗ | 2.566 | 0.000 | 30.229 | 41.237 |
| FU | 34.067∗ | 2.824 | 0.000 | 28.009 | 40.124 | |
| Post | Pre | -35.733∗ | 2.566 | 0.000 | -41.237 | -30.229 |
| FU | -1.667 | 1.912 | 0.398 | -5.767 | 2.433 | |
| FU | Pre | -34.067∗ | 2.824 | 0.000 | -40.124 | -28.009 |
| Post | 1.667 | 1.912 | 0.398 | -2.433 | 5.767 | |